DEREGULATION OF CYCLIN-D1 AND CYCLIN-E AND SUPPRESSION OF CDK2 AND CDK4 IN SENESCENT HUMAN FIBROBLASTS

被引:0
|
作者
LUCIBELLO, FC [1 ]
SEWING, A [1 ]
BRUSSELBACH, S [1 ]
BURGER, C [1 ]
MULLER, R [1 ]
机构
[1] UNIV MARBURG, INST MOLEK BIOL & TUMORFORSCH, EMIL MANNKOPFF STR 2, W-3550 MARBURG, GERMANY
关键词
SENESCENCE; CELL CYCLE; CYCLIN-D; CYCLIN-E; CDK2; CDK4; CDK5; GENE EXPRESSION; PROTEIN KINASE ACTIVITY;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The state of cellular senescence is characterised by an irreversible arrest in the G1 phase of the cell cycle. It has previously been shown that three cell cycle genes, cyclin A, cyclin B and cdc2, are not expressed in senescent human fibroblasts. All three gene products have functions after S-phase entry, so that their suppression cannot explain the irreversible G1 arrest. Here, we report that the abundance of transcripts from two other cell cycle genes, cdk2 and cdk4, thought to act during G1-->S progression, is significantly diminished in senescent cells of the diploid human fibroblast line WI-38. Surprisingly, two other cyclins, D1 and E, behave in a completely different way, in that their expression is elevated in senescent cells, especially under conditions of serum starvation. Both the synthesis and the steady-state level of cyclin D1 protein were also found to be markedly higher in senescent cells (3- to 6-fold). Cyclins D1 and E are thus the first genes shown to be overexpressed or deregulated in senescent cells. It is tempting to speculate that this deregulation may be due to the absence, in senescent cells, of a regulatory loop that would normally control their expression. This is supported by our finding that cyclin E-associated kinase activity in senescent cells is reduced approx. 14-fold. Our data also suggest that the deregulated expression of cyclin DI and E is not sufficient to drive senescent cells into DNA replication.
引用
收藏
页码:123 / 133
页数:11
相关论文
共 50 条
  • [41] Unusual regulation of cyclin D1 and cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse
    Kastner, A
    Moyse, E
    Bauer, S
    Jourdan, F
    Brun, G
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (06) : 2343 - 2349
  • [42] Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins
    Zariwala, M
    Liu, JD
    Xiong, Y
    ONCOGENE, 1998, 17 (21) : 2787 - 2798
  • [43] Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins
    Maimoona Zariwala
    Jidong Liu
    Yue Xiong
    Oncogene, 1998, 17 : 2787 - 2798
  • [44] The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2
    Kitagawa, M
    Higashi, H
    Jung, HK
    SuzukiTakahashi, I
    Ikeda, M
    Tamai, K
    Kato, J
    Segawa, K
    Yoshida, E
    Nishimura, S
    Taya, Y
    EMBO JOURNAL, 1996, 15 (24): : 7060 - 7069
  • [45] Differential regulation of CDP/Cux p110 by cyclin A/Cdk2 and cyclin A/Cdk1
    Santaguida, M
    Nepveu, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (38) : 32712 - 32721
  • [46] Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
    Pack, Lindsey R.
    Daigh, Leighton H.
    Chung, Mingyu
    Meyer, Tobias
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [47] Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
    Lindsey R. Pack
    Leighton H. Daigh
    Mingyu Chung
    Tobias Meyer
    Nature Communications, 12
  • [48] Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers
    Gudas, JM
    Payton, M
    Thukral, S
    Chen, E
    Bass, M
    Robinson, MO
    Coats, S
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (01) : 612 - 622
  • [49] DIFFERENT ROLES FOR CYCLIN-D1 AND CYCLIN-E IN REGULATION OF THE G(1)-TO-S TRANSITION
    RESNITZKY, D
    REED, SI
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (07) : 3463 - 3469
  • [50] Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
    Kang, Jian
    Sergio, C. Marcelo
    Sutherland, Robert L.
    Musgrove, Elizabeth A.
    BMC CANCER, 2014, 14